nidufexor nidufexor nidufexor (lmb-763) is a drug which acts as a partial agonist of the farnesoid x receptor (fxr). it has reached phase ii clinical trials for the treatment of diabetic nephropathy and nonalcoholic steatohepatitis. nidufexoridentifiers iupac name 4-benzoic acid cas number1773489-72-7pubchem cid118063735chemspider57617776uniicj1pl0te6jchemblchembl4297626chemical and physical dataformulac27h22cln3o4molar mass487.94 g·mol−13d model (jsmol)interactive image smiles cn1c2=c(coc3=c2c=c(c=c3)cl)c(=n1)c(=o)n(cc4=cc=cc=c4)cc5=cc=c(c=c5)c(=o)o inchi inchi=1s/c27h22cln3o4/c1-30-25-21-13-20(28)11-12-23(21)35-16-22(25)24(29-30)26(32)31(14-17-5-3-2-4-6-17)15-18-7-9-19(10-8-18)27(33)34/h2-13h,14-16h2,1h3,(h,33,34)key:jytixgyxbibomn-uhfffaoysa-n